Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008824 |
---|---|
Receipt number | R000010348 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for patient with advanced esophageal cancer resistant to standard therapies . |
Date of disclosure of the study information | 2012/08/31 |
Last modified on | 2019/10/30 15:31:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/08/31 16:59:26 | ||
2 | Update | 2012/09/10 10:41:10 | Key inclusion criteria |
|
3 | Update | 2014/07/14 16:17:12 | Division name Division name Address Address TEL TEL Institute Institute Organization Organization Category of Funding Organization |
|
4 | Update | 2014/12/12 12:06:32 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2019/01/07 11:04:36 | Recruitment status |
|
6 | Update | 2019/10/30 15:31:47 | Recruitment status Date of IRB Last follow-up date |